Investing.com -- Shares of Novo Nordisk (NYSE:NVO ... Analyst Sachin Jain at BofA Securities questioned if this was an offensive or defensive move. An offensive move would advance other ...

On Wednesday, BMO Capital Markets reiterated its Market Perform rating on Novo Nordisk (NYSE: NVO) shares, maintaining a price target of $64.00.According to InvestingPro data, Novo Nordisk, with ...

Company sources said Toyota plans to increase PHEVs from 2.4% last year to roughly 20% of its U.S. sales volume by 2030.

Macy’s beat earnings estimates for the first quarter, but cut its 2025 profit outlook as tariffs complicate its turnaround ...

Salesforce delivered a beat-and-raise quarter even with President Trump’s imposition of tariffs on imported goods.

Novo Nordisk announced the decision on Friday. Days earlier, Novo Nordisk cut its sales and profit forecast for the first time since the launch of Wegovy four years ago, though Jorgensen had ...

Despite Lars Fruergaard Jørgensen's resignation as Novo Nordisk's CEO, its stock price has risen 10% over the past two weeks.

I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...

Assuming this is indeed what's happening, Noom's approach might boost Novo Nordisk sales of Wegovy as Noom becomes a reseller of Novo's drug. This would appear to offer a way for Noom (and other ...

Despite Novo Nordisk's stock decline, the company's competitive position is strengthening, driven by strong sales growth in Wegovy, Ozempic, and rare diseases. Eli Lilly's oral weight-loss drug ...